Dexmedetomidine Versus Lidocaine Infusions as Adjuvants to General Anesthesia for Chronic Pain Management After Mastectomy
Condition(s) studied
Investigational drug(s) / intervention(s)
Dexmedetomidine: Patients will receive 1 μg/kg of intravenous dexmedetomidine over 10 min followed by an intravenous infusion of 0.5 μg/kg/h.
Lidocaine: Patients will receive a bolus of intravenous lidocaine 1.5mg/kg over 10 min followed by a continuous infusion of lidocaine 1.5mg/kg/h.
Isotonic saline: Patients will receive intravenous isotonic saline 0.9% in the same volume and manner as the study drugs.
Study summary
This study aims to compare dexmedetomidine and lidocaine infusions as adjuvants to general anesthesia for chronic pain management after mastectomy.
Eligibility
Primary outcome measure(s)
- Incidence of the chronic pain — 6 months postoperatively
Incidence of the chronic pain will be recorded.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Cairo University | Cairo | Egypt | Recruiting |
More Cairo University trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06910644 on ClinicalTrials.gov ↗ ← All trials in Egypt